Advances in cell therapy research

Fang Li, Quan Li, Xue Fu, Lihua Hui, Xuewei Mao, Ran An, Lingfeng Wang

Discussion of Clinical Cases ›› 2023, Vol. 10 ›› Issue (3) : 25-32.

PDF
Discussion of Clinical Cases ›› 2023, Vol. 10 ›› Issue (3) : 25-32. DOI: 10.5430/dcc.v10n3p25
REVIEW

Advances in cell therapy research

Author information +
History +

Abstract

Cell therapy represents an important area of biotechnology, with the potential to treat and even cure a variety of diseases that cannot be cured by traditional therapies. Cell therapy is currently a widely studied treatment in both preclinical and clinical settings, and many cell therapy products are undergoing clinical trials. This article reviews the application of cell therapy in a variety of diseases and the policy of stem cell therapy in China.

Keywords

Cell therapy / Stem cells / Immunological cells / Policy

Cite this article

Download citation ▾
Fang Li, Quan Li, Xue Fu, Lihua Hui, Xuewei Mao, Ran An, Lingfeng Wang. Advances in cell therapy research. Discussion of Clinical Cases, 2023, 10(3): 25‒32 https://doi.org/10.5430/dcc.v10n3p25

References

[1]
Mahla RS. Stem Cells Applications in regenerative medicine and disease therapeutics. Int J Cell Biol. 2016; 2016: 6940283. https://doi.org/10.1155/2016/6940283
[2]
Jäkel CE, Schmidt-Wolf IG. An update on new adoptive immunotherapy strategies for solid tumors with cytokine-inducedkiller cells. Expert Opin BiolTher. 2014; 14(7): 905-916. https://doi.org/10.1517/14712598.2014.900537
[3]
Rosenberg SA, Restifo NP. Adoptive cell transfer as personalized immunotherapy for human cancer. Science. 2015; 348(6230): 62-68. https://doi.org/10.1126/science.aaa4967
[4]
Thomas ED, Buckner CD, Clift RA, et al. Marrow transplantation for acute non lymphoblastic leukemia in first remission. N Engl J Med. 1979; 301: 597-9. https://doi.org/10.1056/NEJM197909133011109
[5]
Lanitis E, Coukos G, Irving M. All systems go: converging synthetic biology and combinatorial treatment for CAR-T cell therapy. Curr. Opin. Biotechnol. 2020; 65: 75-87. https://doi.org/10.1016/j.copbio.2020.01.009
[6]
Riedell Peter A, Bishop Michael R. Safety and efficacy of axicabtagene ciloleucel in refractory large B-cell lymphomas. Ther Adv Hematol. 2020; 11: 2040620720902899. https://doi.org/10.1177/2040620720902899
[7]
Clifford DM, Fisher SA, Brunskill SJ, et al. Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev. 2012; 2: CD006536. https://doi.org/10.1002/14651858.CD006536.pub3
[8]
Shiba Y, Gomibuchi T, Seto T, et al. Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts. Nature. 2016; 538: 388-391. https://doi.org/10.1038/nature19815
[9]
Vagnozzi RJ, Maillet M, Sargent MA, et al. An acute immune response underlies the benefit of cardiac stem cell therapy. Nature. 2020; 577: 405-409. https://doi.org/10.1038/s41586-019-1802-2
[10]
Cao B, Lin J, Zhong Y, et al. Clinical study on the treatment of liver cirrhosis and hepatic insufficiency by autologous bone marrow cell transplantation via portal vein. Chinese Journal of General Surgery. 2007; 22(5): 386-389.
[11]
Wang S, Xu J. Clinical observation on 150 cases of decompensated liver cirrhosis treated with autologous bone marrow stem cell transplantation via hepatic artery catheterization. Chinese Community Doctors. 2013; 15(04): 33-34.
[12]
Terai S, Ishikawa T, Omori K, et al. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells. 2006; 24: 2292-8. https://doi.org/10.1634/stemcells.2005-0542
[13]
Ai G, Meng M, Guo J, et al. Adipose-derived stem cells promote the repair of chemotherapy-induced premature ovarian failure by inhibiting granulosa cells apoptosis and senescence. Stem Cell Res Ther. 2023; 14(1): 75. https://doi.org/10.1186/s13287-023-03297-5
[14]
Tfilin M, Sudai E, Merenlender A, et al. Mesenchymal stem cells increase hippocampal neurogenesis and counteract depressive-like behavior. Mol Psychiatry. 2010; 15(12): 1164-75. https://doi.org/10.1038/mp.2009.110
[15]
Mishra SK, Rana P, Khushu S, et al. Therapeutic Prospective of Infused Allogenic Cultured Mesenchymal Stem Cells in Traumatic Brain Injury Mice: A Longitudinal Proton Magnetic Resonance Spectroscopy Assessment. Stem Cells Transl Med. 2017; 6(1): 316-29. https://doi.org/10.5966/sctm.2016-0087
[16]
Nijboer CH, Kooijman E, van Velthoven CT, et al. Intranasal Stem Cell Treatment as a Novel Therapy for Subarachnoid Hemorrhage. StemCells Dev. 2018; 27(5): 313-25. https://doi.org/10.1089/scd.2017.0148
[17]
Jiang HY, Wang JP, Bai YH, et al. Clinical observation of umbilical cord mesenchymal stem cell transplantation for treating patients receiving peritoneal dialysis. Minerva Urology and Nephrology. 2018; 70(1). https://doi.org/10.23736/S0393-2249.17.02869-7
[18]
Du Y, Zong M, Guan Q, et al. Comparison of mesenchymal stromal cells from peritoneal dialysis effluent with those from umbilical cords: characteristics and therapeutic effects on chronic peritoneal dialysis in uremic rats. Stem Cell Res Ther. 2021; 12(1): 398. https://doi.org/10.1186/s13287-021-02473-9
[19]
Xian Y, Lin Y, Cao C, et al. Protective effect of umbilical cord mesenchymal stem cells combined with resveratrol against renal podocyte damage in NOD mice. Diabetes Research and Clinical Practice. 2019; 156. https://doi.org/10.1016/j.diabres.2019.05.034
[20]
Nair GG, Liu JS, Russ HA, et al. Recapitulating endocrine cell clustering in culture promotes maturation of human stem-cell-derived beta cells. 2019; 21(2): 263-74. https://doi.org/10.1038/s41556-018-0271-4
[21]
Kong D, Zhuang X, Wang D, et al. Umbilical cord mesenchymal stem cell transfusion ameliorated hyperglycemia in patients with type 2 diabetes mellitus. Clin. Lab. 2014; 60: 1969-76. https://doi.org/10.7754/Clin.Lab.2014.140305
[22]
Wang L, Wang L, Cong X, et al. Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: safety and efficacy. Stem Cells Dev. 2013; 22(24): 3192-3202. https://doi.org/10.1089/scd.2013.0023
[23]
Jo CH, Lee YG, Shin WH, et al. Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a proof-of-concept clinical trial. Stem cells. 2014; 32(5): 1254-1266. https://doi.org/10.1002/stem.1634
[24]
Shadmanfar S, Labibzadeh N, Emadedin M, et al. Intra-articular knee implantation of autologous bone marrow-derived mesenchymal stromal cells in rheumatoid arthritis patients with knee involvement: Results of a randomized, triple-blind, placebo-controlled phase 1/2 clinical trial. Cytotherapy. 2018. https://doi.org/10.1016/j.jcyt.2017.12.009
[25]
Pratheesh MD, Gade NE, Nath A, et al. Evaluation of persistence and distribution of intra-dermally administered PKH 26 labelled goat bone marrow derived mesenchymal stem cells in cutaneous wound healing model. Cytotechnology. 2017; 69(6): 841-849. https://doi.org/10.1007/s10616-017-0097-0
[26]
Rasulov MF, Vasilchenkov AV, Onishchenko NA, et al. First experience of the use bone marrow mesenchymal stem cells for the treatment of a patient with deep skin burns. Bulletin of experimental biology and medicine. 2005; 139(1): 141-4. https://doi.org/10.1007/s10517-005-0232-3
[27]
Wu S, Yang S, Wu Z. Research on cell therapy regulatory policies in the United States, the European Union, and Japan. Chinese Medicinal Biotechnology. 2016; 11(6): 491-496.
PDF

Accesses

Citations

Detail

Sections
Recommended

/